InfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU), a key provider of outpatient care for durable medical equipment, will participate in Craig-Hallum’s 13th Annual Alpha Select Conference on November 17, 2022, at the Sheraton New York Times Square. CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance will be present for one-on-one meetings. InfuSystem operates under two platforms: Integrated Therapy Services and Durable Medical Equipment Services, serving various healthcare needs across the U.S. and Canada.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)-- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer, Barry Steele, Chief Financial Officer, and Carrie Lachance, President and Chief Operating Officer, will participate at Craig-Hallum’s 13th Annual Alpha Select Conference on Thursday, November 17, 2022. The conference will be held at the Sheraton New York Times Square in New York City.

Management is scheduled to host one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings should contact your Craig-Hallum conference representative. Conversely, you may also call or email Lytham Partners at 602-889-9700, or infu@lythampartners.com.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Integrated Therapy Services (“ITS”), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services (“DME Services”), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, our share repurchase program and capital allocation strategy, business plans, strategic partnerships, growth initiatives, objectives and prospects, future operating or financial performance, guidance and expected new business relationships and the terms thereof (including estimated potential revenue under new or existing contracts). The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “goal,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our ability to successfully execute on our growth initiatives and strategic partnerships, our ability to enter into definitive agreements for the new business relationships on expected terms or at all, our ability to generate estimated potential revenue amounts under new or existing contracts, the uncertain impact of the COVID-19 pandemic, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law, supply chain disruptions, contributions from acquired businesses or new business lines, products or services and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. Our strategic partnerships are subject to similar factors, risks and uncertainties. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.

Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110006003/en/

Joe Dorame, Joe Diaz & Robert Blum

Lytham Partners, LLC

602-889-9700

Source: InfuSystem Holdings, Inc.

FAQ

What is InfuSystem's participation in the Craig-Hallum Conference 2022?

InfuSystem will participate in Craig-Hallum’s 13th Annual Alpha Select Conference on November 17, 2022, in New York City.

Who will represent InfuSystem at the conference?

CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance will represent InfuSystem at the conference.

What services does InfuSystem provide?

InfuSystem provides outpatient care services primarily through Integrated Therapy Services and Durable Medical Equipment Services.

Where is InfuSystem headquartered?

InfuSystem is headquartered in Rochester Hills, Michigan.

How can investors contact InfuSystem for meetings?

Investors can contact Craig-Hallum conference representatives or email Lytham Partners at infu@lythampartners.com.